No Picture
Newsmakers

Applied UV (NASDAQ: AUVI) Announces International Dealer Awarded Sole Source Provider Contract for Airocide’s FDA Class II Listed Medical Device

Airocide to be Deployed in Pakistan Government Hospitals Expands Global Footprint with Distribution Now in 52 Countries MOUNT VERNON, N.Y., June 09, 2022–Applied UV, Inc. (NASDAQ: AUVI) (“Applied UV” or the “Company”), a pathogen elimination technology company […]

No Picture
Healthcare

Stealth BioTherapeutics (NASDAQ: MITO) Presents New SBT-272 Data Demonstrating Improvement in Upper Motor Neuron Function in ALS Disease Model at Keystone Neurodegeneration Symposium

SBT-272 improved neuronal health, superior to other approved and investigational agents Phase 1 study to evaluate safety and tolerability of SBT-272 in healthy volunteers is underway BOSTON, June 8, 2022 — Stealth BioTherapeutics Corp (NASDAQ: MITO), […]

No Picture
Healthcare

FDA Advisory Committee Recommends Emergency Use Authorization of Novavax (NASDAQ: NVAX) COVID-19 Vaccine for People Aged 18 Years and Older

Novavax COVID-19 vaccine receives positive vote from U.S. Food and Drug Administration Vaccines and Related Biological Products Advisory Committee If Emergency Use Authorization is granted by the FDA, the Novavax COVID-19 vaccine would become the […]

Healthcare

Nova Mentis (OTC: NMLSF) Receives Controlled Substances Export Approval From The U.S. DEA For The Company’s Proprietary Psilocybin Drug NM 1001

Vancouver, British Columbia– June 7, 2022 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory […]

Newsmakers

DeepMarkit (OTC: MKTDF) Contributes Response to Current Industry Dialogue Regarding Tokenization of Carbon Credits

The Company’s MintCarbon.io platform mints only 100% verified carbon credits registered on the Gold Standard or Verra Registries and Other Reputable Registries Retired, Expired or Otherwise Inferior Credits are not Eligible for Minting on MintCarbon.io […]

Newsmakers

DeepMarkit (OTC: MKTDF) Welcomes Added Validation of its Business Model as Venture Capital Firms Lead US$70 Million Investment in Recent Industry Deal

VC Firms Andreessen Horowitz, General Catalyst and Samsung Next, to name a few, backed the latest large deal that is drawing attention to the carbon credit industry Flowcarbon’s ability to raise US$70 Million demonstrates a growing level […]

No Picture
Healthcare

Kiromic BioPharma (NASDAQ: KRBP) Significantly Expands Gamma Delta T cell Product Pipeline with New Sponsored Research Agreement

In Vivo Preclinical Data Expected to Enable Three New IND Applications to Evaluate Company’s Gamma Delta T cell Product Candidates Procel™, Isocel™, and Deltacel™ HOUSTON, June 07, 2022—-Kiromic BioPharma, Inc. (NASDAQ: KRBP), a clinical-stage biotherapeutics company […]

No Picture
Healthcare

Tonix Pharmaceuticals (NASDAQ: TNXP) Announces Issuance of U.S. Patent for TNX-801 Smallpox and Monkeypox Vaccine and Recombinant Pox Virus (RPV) Platform Technology

Strengthens Patent Portfolio Protecting Horsepox-Based Live Virus Vaccines TNX-1840 and TNX-1850 are Potential RPV Vaccines Designed to Protect Against COVID-19 Confirms Leadership Position in Synthetic Biology Statutory Term of New Patent Expected to Provide Exclusivity […]

Newsmakers

DeepMarkit (OTC: MKTDF) Secures Carbon Credits for Second Stage MintCarbon.io Platform Test and NFT Market Validation

MintCarbon.io platform to be tested with a higher volume of carbon credits than has been performed to date Post-mint NFT pricing and secondary market transactions to be observed in proof-of-market validation DeepMarkit and Climate Carbon […]

Newsmakers

PharmaDrug (OTC: LMLLF) Announces Closing of the First Tranche of Non-Brokered Private Placement

Toronto, Ontario– May 27, 2022 – PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) (“PharmaDrug” or the “Company“), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, […]